Antibodies

03 Jan 2008 ImmunoGen, Inc. Expands Pipeline of Targeted Anticancer Compounds
03 Jan 2008 Expanded Labeling for MabCampath(R) in Europe
30 Dec 2007 MorphoSys Files Clinical Trial Application to Initiate First Phase 1 Clinical Study of its MOR103 Program
22 Dec 2007 Elan and Wyeth Dose First Patient in North America in Phase 3 Program for Bapineuzumab (AAB-001) in Alzheimer's Disease
21 Dec 2007 Centocor, Schering-Plough Revise Agreement Covering REMICADE, Golimumab
21 Dec 2007 Fresenius Biotech applies for the marketing authorization of the trifunctional antibody Removab (R) for the treatment of malignant ascites
21 Dec 2007 Ablinx Extends Agreement With Wyeth
20 Dec 2007 Human Genome Sciences initiates second randomized Phase 2 trial of HGS- ETR 1 in combination with chemotherapy
20 Dec 2007 R1507 antibody to enter Phase II study to treat sarcoma
20 Dec 2007 Abbott's HUMIRA (R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
19 Dec 2007 Avastin approved in Europe for first-line treatment of patients with advanced kidney cancer
17 Dec 2007 Auxilium Pharmaceuticals, Inc. Completes Enrollment in Two Phase III Clinical Trials of XIAFLEX(TM) for Dupuytren's Contracture
17 Dec 2007 Ablynx Reports Positive Phase I Results for Its Anti-Thrombotic Nanobody(R), ALX-0081
14 Dec 2007 Pivotal Phase 3 Data Show Denosumab Increased Bone Density Throughout Skeleton in Non-Metastatic Breast Cancer Patients on Adjuvant Aromatase Inhibitor Therapy
14 Dec 2007 WILEX announces positive result of the interim analysis for futility of its Phase III ARISER trial with RENCAREX(R)
13 Dec 2007 Merck Announces Initiation of Phase II/III Clinical Trial of Atacicept in Lupus Nephritis
13 Dec 2007 Genmab announces details of planned Ofatumumab Phase II study in multiple sclerosis
13 Dec 2007 Genmab initiates Ofatumumab Phase II study in diffuse large b-cell lymphoma
11 Dec 2007 ThromboGenics Presents Results of the Phase I Trial of TB-402 at thePrestigious American Society of Hematology Annual Meeting
11 Dec 2007 Fourth Genmab Antibody Developed Under Roche Collaboration to Enter Clinic
11 Dec 2007 Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH
11 Dec 2007 GlaxoSmithKline and OncoMed Pharmaceuticals Form Strategic Alliance to Develop Cancer Stem Cell Antibody Therapeutics
10 Dec 2007 Genitope Corporation Presents New Data On Its Therapeutic Monoclonal Antibodies To Potentially Treat B-Cell Malignancies
10 Dec 2007 MorphoSys Broadens Scope of Collaboration with GeneFrontier
10 Dec 2007 PDL BioPharma Presents Data on Novel Monoclonal Antibody for Multiple Myeloma at the 2007 American Society of Hematology Annual Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up
Top